nandrolone has been researched along with oxendolone in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (61.90) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanai, Y; Kondo, T; Tanayama, S; Yoshida, K | 1 |
| Fuse, H; Ishikawa, S; Katayama, T; Kazama, T; Mizuno, I; Takamine, T; Terada, T; Umeda, K | 1 |
| Umeda, K | 1 |
| Ezumi, K; Horibe, I; Matsumoto, K; Nishizawa, Y; Suzuki, T; Takeda, K; Tanaka, A; Uchida, K; Uchida, N | 1 |
| Bashirelahi, N; Ekiko, DB; Ganesan, S; Shida, K; Takahashi, E; Yamanaka, H; Young, JD | 1 |
| Aoyama, T; Furuya, S; Honma, A; Kumamoto, Y; Miyamoto, S; Takagi, Y; Takatsuka, K; Tamiya, T; Tsukamoto, T; Yokoyama, E | 1 |
| Kawase, M; Nakayama, R; Oishi, K; Okada, K; Sudo, K; Yoshida, O | 2 |
| Andersson, T; Frimodt-Møller, C; Lindgård, G; Meyhoff, HH; Nielsen, MS; Ostri, P; Petersen, JH; Swartz, R | 1 |
| Fujii, M; Fujiwara, H; Kitano, T; Kodama, M; Matsuki, S; Nihira, H; Sagami, K; Tado, O; Ukai, R; Yasukawa, A | 1 |
| Nakayama, R; Sudo, K; Yoshida, K | 1 |
| Goto, G; Hiraga, K; Miki, T; Sumi, M | 1 |
| Chasseaud, LF; Darragh, A; Fowkes, AG; Lambe, R; Midgley, I; Taylor, T | 1 |
| Hiraga, K; Masuoka, M; Nakayama, R; Sudo, K; Yoshida, K | 1 |
| Matuo, Y; Nishi, N; Wada, F | 1 |
| Akinaga, Y; Nakayama, R; Sudo, K; Yoshida, K | 1 |
| Iguchi, H; Ikeuchi, T; Kai, Y; Yoshida, H | 1 |
| Fushiki, T; Inoue, K; Okada, Y; Sugimoto, E; Yamasaki, S | 1 |
| Komatsu, H; Ohta, A; Yamada, K | 1 |
| Asanuma, Y; Kubo, M; Matsuda, H; Naruo, S; Yamazaki, M | 1 |
| Hara, T; Hikichi, Y; Kusaka, M; Yamaoka, M | 1 |
2 trial(s) available for nandrolone and oxendolone
| Article | Year |
|---|---|
[Clinical efficacy of oxendolene (antiandrogen) and bunazosin hydrochloride (alpha-adrenergic blocker) in the treatment of prostatism--comparative study of oxendolone, bunazocin hydrochloride and their combination].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androgen Antagonists; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nandrolone; Prostatic Hyperplasia; Quinazolines; Urinary Bladder Neck Obstruction; Urination | 1987 |
Antiandrogenic treatment of benign prostatic hyperplasia: a placebo controlled trial.
Topics: Aged; Androgen Antagonists; Double-Blind Method; Humans; Male; Multicenter Studies as Topic; Nandrolone; Prospective Studies; Prostatic Hyperplasia; Random Allocation; Urination | 1989 |
19 other study(ies) available for nandrolone and oxendolone
| Article | Year |
|---|---|
Disposition and metabolism of 16 beta-ethyl-17 beta-hydroxy-4-estern-3-one (TSAA-291), a new antiandrogen, in rats.
Topics: Androgen Antagonists; Animals; Bile; Chemical Phenomena; Chemistry; Chromatography, Gas; Feces; Kidney; Liver; Male; Mass Spectrometry; Nandrolone; Rats; Tissue Distribution | 1979 |
[Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography].
Topics: Administration, Oral; Androgen Antagonists; Chlormadinone Acetate; Humans; Injections, Intramuscular; Male; Nandrolone; Prostate; Prostatic Hyperplasia; Ultrasonography | 1990 |
[Clinical results and problems of anti-androgen therapy of benign prostatic hypertrophy].
Topics: Administration, Oral; Aged; Allylestrenol; Androgen Antagonists; Chlormadinone Acetate; Humans; Injections, Intramuscular; Male; Nandrolone; Prostatic Hyperplasia | 1991 |
Effects of antiandrogens on growth of androgen-dependent mouse mammary tumor (Shionogi carcinoma 115) in vivo and in vitro.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Aniline Compounds; Animals; Cell Division; Male; Mammary Neoplasms, Experimental; Mice; Nandrolone; Receptors, Androgen; Steroids; Tumor Cells, Cultured | 1990 |
Effect of 16 beta-ethyl-17 beta-hydroxy-4-estren-3-one (TSAA-291) on the binding of promegestone (R5020) and methyltrienolone (R1881) to hyperplastic and neoplastic human prostate.
Topics: Binding, Competitive; Centrifugation, Density Gradient; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Estrenes; Humans; Male; Mathematics; Metribolone; Nandrolone; Norpregnadienes; Promegestone; Prostatic Hyperplasia | 1986 |
Study of the effect of an anti-androgen (oxendolone) on experimentally induced canine prostatic hyperplasia. I. Morphological analysis.
Topics: Androstane-3,17-diol; Animals; Dogs; Estradiol; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Nandrolone; Prostate; Prostatic Hyperplasia; Testosterone | 1988 |
Study of the effect of an anti-androgen (oxendolone) on experimentally induced canine prostatic hyperplasia. II. Endocrinological analysis.
Topics: Animals; Dihydrotestosterone; Dogs; Estradiol; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Nandrolone; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Estrogen; Testosterone | 1988 |
[Clinical experience with oxendolone for treatment of benign prostatic hyperplasia. Clinical efficacy and effects on serum lipid and lipoprotein fraction levels].
Topics: Aged; Androgen Antagonists; Drug Evaluation; Humans; Lipids; Lipoproteins; Male; Middle Aged; Nandrolone; Prostatic Hyperplasia | 1984 |
Specific interaction of radioactive anti-androgen TSAA-291 with androgen receptor in rat prostates.
Topics: Animals; Cell Nucleus; Corticosterone; Cyproterone; Cyproterone Acetate; Cytosol; Dihydrotestosterone; Macromolecular Substances; Male; Nandrolone; Prostate; Rats; Rats, Inbred Strains; Receptors, Androgen; Receptors, Steroid | 1982 |
[Alternative synthesis of 16beta-ethyl-17beta-hydroxyester-4-en-3-one (oxendolone)].
Topics: Androgen Antagonists; Dehydroepiandrosterone; Nandrolone | 1983 |
The metabolic fate of the anti-androgenic agent, oxendolone, in man.
Topics: Adult; Androgens; Biotransformation; Carbon Radioisotopes; Chromatography, Thin Layer; Estradiol; Feces; Follicle Stimulating Hormone; Humans; Injections, Intramuscular; Kinetics; Luteinizing Hormone; Male; Nandrolone | 1983 |
Radioimmunoassay for serum levels of an anti-androgen TSAA-291 (Oxendolone) in rats.
Topics: Animals; Chromatography, Gas; Male; Nandrolone; Organ Size; Prostate; Radioimmunoassay; Rats; Rats, Inbred Strains; Seminal Vesicles; Testis | 1984 |
Biochemical difference between ventral and dorsolateral prostates: effects of castration and administration of the antiandrogen 16 beta-ethyl-17 beta-hydroxy-4-oestren-3-one on SDS-electrophoretic patterns of subcellular proteins from rat prostates.
Topics: Androgen Antagonists; Animals; Body Weight; Castration; Cell Nucleus; Cytosol; DNA; Electrophoresis, Polyacrylamide Gel; Male; Nandrolone; Nucleoproteins; Organ Size; Prostate; Proteins; Rats; Sodium Dodecyl Sulfate | 1984 |
5alpha-reduction of an anti-androgen TSAA-291, 16beta-ethyl-17beta-hydroxy-4-estren-3-one, by nuclear 5alpha-reductase in rat prostates.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Cell Nucleus; Chromatography, Thin Layer; Male; Nandrolone; Oxidation-Reduction; Oxidoreductases; Prostate; Rats; Testosterone | 1981 |
[Influence of anti-androgen therapy for prostatic hypertrophy on lipid metabolism].
Topics: Aged; Aged, 80 and over; Allylestrenol; Androgen Antagonists; Chlormadinone Acetate; Gestonorone Caproate; Humans; Lipid Metabolism; Lipids; Lipoproteins, HDL; Male; Malondialdehyde; Middle Aged; Nandrolone; Prostatic Hyperplasia | 1994 |
Androgen receptor antagonist suppresses exercise-induced hypertrophy of skeletal muscle.
Topics: Androgen Receptor Antagonists; Animals; Electric Stimulation; Hypertrophy; Male; Muscle, Skeletal; Nandrolone; Organ Size; Physical Exertion; Prostate; Rats; Rats, Sprague-Dawley; Receptors, Androgen | 1994 |
Effects of 3,6-dimethylpyrazine-2-thiol on reproductive and accessory reproductive organs in male rats.
Topics: Androgen Antagonists; Animals; Genitalia, Male; Male; Nandrolone; Orchiectomy; Organ Size; Prostate; Pyrazines; Rats; Rats, Wistar; Reproduction; Seminal Vesicles; Testis; Testosterone | 1996 |
Anti-androgenic and hair growth promoting activities of Lygodii spora (spore of Lygodium japonicum) I. Active constituents inhibiting testosterone 5alpha-reductase.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Cricetinae; Enzyme Inhibitors; Fatty Acids; Ferns; Hair; Male; Mice; Mice, Inbred C57BL; Nandrolone; Spores; Testosterone | 2002 |
Selective androgen receptor modulator activity of a steroidal antiandrogen TSAA-291 and its cofactor recruitment profile.
Topics: Androgen Receptor Antagonists; Androgens; Animals; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; HEK293 Cells; Humans; Male; Mice, Inbred ICR; Muscle, Skeletal; Nandrolone; Orchiectomy; Prostate; Protein Binding; Protein Inhibitors of Activated STAT; Receptors, Androgen; Seminal Vesicles; Transfection; Two-Hybrid System Techniques | 2015 |